Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of Menveo versus Nimenrix in healthy toddlers
2013-000862-13Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in meningococcal disease comparing Menveo with Nimenrix (2 arms). Primary endpoint: Severe solicited adverse events. Started May 2013; status: completed.
02
Drugs
meningococcal A conjugate vaccineMeningococcal polysaccharide vaccine group W-135
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2013-000862-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000862-13.